tandospirone has been researched along with Movement Disorders in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Awaya, T; Chiba, K; Matsubara, K; Noda, T; Ogawa, K; Ohtaki, K; Satomi, M; Shimizu, K; Shiono, H; Suno, M; Tasaki, Y; Yamada, T | 1 |
1 other study(ies) available for tandospirone and Movement Disorders
Article | Year |
---|---|
Tandospirone, a 5-HT1A agonist, ameliorates movement disorder via non-dopaminergic systems in rats with unilateral 6-hydroxydopamine-generated lesions.
Topics: Analysis of Variance; Animals; Apomorphine; Behavior, Animal; Benzazepines; Brain Injuries; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Functional Laterality; Isoindoles; Male; Movement Disorders; Oxidopamine; Piperazines; Pyridines; Pyrimidines; Rats; Rats, Wistar; Rotarod Performance Test; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors | 2006 |